Orion Corporation

Overview

Orion Corporation is a Finnish pharmaceutical company specializing in the discovery, development, and manufacturing of pharmaceuticals. It focuses on several therapeutic areas and produces both prescription medicines and self-care products.

Therapeutic areas

API / Drug Master Files

Orion Corporation holds 3 active (32 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• OMIDENEPAG ISOPROPYLActive2020-01-21
• BEPOTASTINE BESILATEActive2006-11-15
• METHYL SALICYLATEActive2001-09-03
• DEXMEDETOMIDINEInactive1991-07-18
• TRIAZOLAMInactive1991-06-26
• FAVOXATE HCLInactive1989-01-16
• TERFENADINEInactive1988-12-08
• PENTOXIFYLLINEInactive1988-10-04
• SELENIUM SULFIDEInactive1987-11-10
• MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN FINLAND.Inactive1987-03-03
• PRAZOSIN HCL ALPHA-FORMInactive1987-02-18
• PRAZOSIN HCL DELTA-FORMInactive1987-02-18
• MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MANKKAA PLANT.Inactive1987-01-26
• TOLMETIN SODIUMInactive1986-12-19
• MINOXIDILInactive1986-06-25

Showing 15 of 32 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Orion Corporation in our records. PharmaTek screens the full directory against live FDA enforcement data.